Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-25-001974
Filing Date
2025-07-08
Accepted
2025-07-08 16:20:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9684
2 ex991to13g10022ptix_070825.htm EX-99.1 5217
  Complete submission text file 0000921895-25-001974.txt   16825
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Subject) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-48089 | Film No.: 251111259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 159 JENNINGS RD COLD SPRING HARBOR NY 11724
Business Address 159 JENNINGS RD COLD SPRING HARBOR NY 11724 631-987-0235
BIGGER CAPITAL FUND L P (Filed by) CIK: 0001288478 (see all company filings)

EIN.: 900131165 | State of Incorp.: DE
Type: SCHEDULE 13G